First clinical experiences with perampanel-The Kork experience in 74 patients
Author:
Affiliation:
1. Kork Epilepsy Center; Kehl-Kork Germany
Publisher
Wiley
Subject
Neurology (clinical),Neurology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/epi.12492/fullpdf
Reference8 articles.
1. Perampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy;Hanada;Epilepsia,2011
2. Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304;French;Neurology,2012
3. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305;French;Epilepsia,2013
4. Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures;Krauss;Neurology,2012
5. Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies;Steinhoff;Epilepsia,2013
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The cenobamate KORK study—A prospective monocenter observational study investigating cenobamate as an adjunctive therapy in refractory epilepsy, with comparisons to historical cohorts treated with add‐on lacosamide, perampanel, and brivaracetam;Epilepsia Open;2024-06-11
2. Long-term efficacy and safety of perampanel as an add-on therapy in patients with epilepsy;Epilepsy Research;2024-02
3. ESPRITE — Efficacy and Safety of adjunctive Perampanel in a prospective, Real‐world, Phase IV study in Indian patients aged ≥12 years for Treatment of focal‐onset Epilepsy: Study 508;Epilepsia Open;2023-12-21
4. PERPRISE: A prospective non‐interventional study of PERampanel as only adjunctive treatment in patients with PRImary or SEcondarily generalized tonic‐clonic seizures: First interim analysis;Epilepsia Open;2023-11-28
5. The broad-spectrum activity of perampanel: state of the art and future perspective of AMPA antagonism beyond epilepsy;Frontiers in Neurology;2023-07-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3